Generic Name and Formulations:
Pseudoephedrine HCl 30mg; tabs.
McNeil Consumer Healthcare
Indications for SUDAFED:
60mg every 4–6 hrs; max 4 doses/24hrs.
<6yrs: use other forms. 6–11yrs: 30mg every 4–6 hrs; max 4 doses/24hrs.
During or within 14 days of MAOIs.
Hypertension. Cardiovascular disease. Diabetes. Thyroid disease. GI or GU obstruction.
Hypertensive crisis with MAOIs. β-blockers increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Nervousness, dizziness, insomnia.
Tabs—24, 48, 96; 12hr—10, 20; 24hr—5, 10
Endocrinology Advisor Articles
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- Effect of Growth Hormone Treatment on BMD in Adults With Prader-Willi Syndrome
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Type 2 Diabetes Associated With Increased Fracture Risk in Postmenopausal Women
- Use of FSH in Early Diagnosis of Turner Syndrome
- Surgical Treatment Better Than Medical Therapy in Severely Obese Adolescents With T2D
- Metformin May Improve Pregnancy Outcomes in Polycystic Ovary Syndrome